Innovative measures to combat rare diseases in China: The national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research

Intractable and Rare Diseases Research

Volumn 6, Issue 1, 2017, Pages 1-5

  Song, Peipei ^a,b   He, Jiangjiang ^a   Li, Fen ^a   Jin, Chunlin ^a  

^a Shanghai Medical Insurance Information Center   (China)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Big data; Diagnosis and treatment; Precision medicine; Predictive model; Rare diseases; Registry system

Indexed keywords

ARTICLE; CHINA; CHINESE; CLINICAL STUDY; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE REGISTRY; GENE LIBRARY; HUMAN; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; PERSONALIZED MEDICINE; PREDICTION; PROGNOSIS; RARE DISEASE; REFERENCE DATABASE;

EID: 85026805135     PISSN: 21863644     EISSN: 2186361X     Source Type: Journal    
DOI: 10.5582/irdr.2017.01003     Document Type: Article

References (25)

1. Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet. 2008; 371:2039-2041.
2. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Intractable and rare diseases research in Asia. Biosci Trends. 2012; 6:48-51.
3. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. Intractable Rare Dis Res. 2012; 1:3-9.
4. Ma D, Li DG, Zhang X, He L. The prevention and treatment of rare diseases in China: Opportunities and challenges. Chinese Journal of Evidence Based Pediatrics. 2011; 6:81-82. (in Chinese)
5. Tang W, Makuuchi M. Intractable and rare diseases research. Intractable Rare Dis Res. 2012; 1:1-2.
6. Chinese Center for Disease Control and Prevention. The total number of cases of rare diseases: Affecting 16.8 million patients in China. http://www.chinacdc.cn/mtdx/mxfcrxjbxx/201409/t20140912_104369.htm (accessed January 3, 2017; in Chinese)
7. Inagaki Y, Song P. Necessity of cooperation with government on publication of scientific research results for intractable diseases. Intractable Rare Dis Res. 2013; 2:69-71.
8. Tang Q, Song P, Chen Y. Measures to combat rare diseases and promote orphan drug development in Japan: Government-funded special biomedical research programs to enhance basic and applied research. Expert Opin Orphan Drugs. 2016; 4:613-619.
9. Hayashi S, Umeda T. 35 years of Japanese policy on rare diseases. Lancet. 2008; 372:889-890.
10. Song P, Kokudo N. Revision of measures to combat intractable diseases in Japan: Three pillars will play an even greater role in the future. Intractable Rare Dis Res. 2013; 2:33-34.
11. Cui Y, Zhou X, Han J. China launched a pilot project to improve its rare disease healthcare levels. Orphanet J Rare Dis. 2014; 9:14.
12. Rare Disease in China. The launch of the national rare disease registration platform: A new milestone for the prevention and treatment of rare diseases. http://www. hanjianbing.org/content/details_12_3358.html (accessed December 20, 2016; in Chinese)
13. Maaroufi M, Choquet R, Landais P, Jaulent MC. Towards data integration automation for the French rare disease registry. AMIA Annu Symp Proc. 2015; 2015:880-885.
14. Tattersfield AE, Glassberg MK. Lymphangioleiomyomatosis: A national registry for a rare disease. Am J Respir Crit Care Med. 2006; 173:2-4.
15. Nagel G, Unal H, Rosenbohm A, Ludolph AC, Rothenbacher D; ALS Registry Study Group. Implementation of a population-based epidemiological rare disease registry: Study protocol of the amyotrophic lateral sclerosis (ALS)-registry Swabia. BMC Neurol. 2013; 13:22.
16. Lau CT, Kan A, Shek N, Tam P, Wong KK. Is congenital pulmonary airway malformation really a rare disease? Result of a prospective registry with universal antenatal screening program. Pediatr Surg Int. 2017; 33:105-108.
17. Shi F, Gong M, Zhang S. The national rare diseases registry system of China and the related cohort studies: Vision and roadmap. Chinese Journal of Endocrinology and Metabolism. 2016, 32:977-982. (in Chinese)
18. EURORDIS. What is a rare disease? http://www.eurordis. org/content/what-rare-disease (accessed December 28, 2016).
19. EURORDIS. Survey of the delay in diagnosis for 8 rare diseases in Europe ('EurordisCare2'). http://www.eurordis. org/publication/survey-delay-diagnosis-8-rare-diseaseseurope-% E2%80%98eurordiscare2%E2%80%99 (accessed December 28, 2016).
20. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015; 372:793-795.
21. Klonoff DC. Precision medicine for managing diabetes. J Diabetes Sci Technol. 2015; 9:3-7.
22. Groza T, Köhler S, Moldenhauer D, et al. The human phenotype ontology: Semantic unification of common and rare disease. Am J Hum Genet. 2015; 97:111-24.
23. Hansson MG, Lochmüller H, Riess O, Schaefer F, Orth M, Rubinstein Y, Molster C, Dawkins H, Taruscio D, Posada M, Woods S. The risk of re-identification versus the need to identify individuals in rare disease research. Eur J Hum Genet. 2016; 24:1553-1558.
24. Frey LJ, Bernstam EV, Denny JC. Precision medicine informatics. J Am Med Inform Assoc. 2016; 23:668-670.
25. National Rare Diseases Registry System of China. Notice of project initiation. http://www.nrdrs.org/emh/data/page/rare/bulletin_artical.html (accessed December 23, 2016).